Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.1%

9 terminated/withdrawn out of 220 trials

Success Rate

92.4%

+5.9% vs industry average

Late-Stage Pipeline

25%

55 trials in Phase 3/4

Results Transparency

15%

16 of 110 completed trials have results

Key Signals

9 recruiting16 with results5 withdrawn

Enrollment Performance

Analytics

N/A

86(53.4%)

Phase 4

38(23.6%)

Phase 3

17(10.6%)

Phase 2

13(8.1%)

Phase 1

7(4.3%)

161Total

N/A(86)

Phase 4(38)

Phase 3(17)

Phase 2(13)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (220)

Showing 20 of 220 trials

NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Role: collaborator

NCT02551250Completed

Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis

Role: collaborator

NCT02433795Phase 2Completed

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Role: collaborator

NCT07447297Not ApplicableRecruiting

Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation

Role: collaborator

NCT07174544Not ApplicableCompleted

Mobile Self-Management Program for Stress Reduction in Young Adults

Role: lead

NCT07319377Not ApplicableRecruiting

Evaluation of Safety and Efficacy of a Digital Therapeutic Device to Improve Strength in Sarcopenia (Sarc-DTx)

Role: collaborator

NCT07256977Not ApplicableNot Yet Recruiting

Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer

Role: collaborator

NCT06984952Not ApplicableRecruiting

Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy

Role: collaborator

NCT05671705Completed

Effect of Sarcopenia in Stroke Patients

Role: lead

NCT05657249Not ApplicableActive Not Recruiting

Alternative Surveillance Program for Patients With High Risk Group of HCC

Role: collaborator

NCT06329141Phase 2Recruiting

A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Role: collaborator

NCT04691674Not ApplicableCompleted

Optimal Placement Duration of Pancreatic Duct Stent

Role: collaborator

NCT05896501Active Not Recruiting

Role of FFR in ACS Patients: Pressure ACS Registry

Role: lead

NCT06367998Phase 4Not Yet Recruiting

Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair

Role: lead

NCT04938076Not ApplicableCompleted

Efficacy of Transcranial Direct Current Stimulation in Acute Ischemic Stroke

Role: collaborator

NCT06138769Phase 2Active Not Recruiting

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Role: collaborator

NCT06475625Phase 4Active Not Recruiting

Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease

Role: lead

NCT05381194Phase 4Recruiting

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Role: collaborator

NCT06177808Not ApplicableUnknown

Assessment of Cutting-Balloon Angioplasty With Everolimus-Eluting Stent(EES) in the Treatment of Coronary Calcified Lesion(CCL) Guided by Intravascular Ultrasonography(IVUS)

Role: collaborator

NCT02936232Recruiting

Severe Sepsis and Septic Shock Registry

Role: collaborator